Relationship between hypothalamic-pituitary-adrenal axis dysregulation and insulin resistance in elderly patients with depression

Psychiatry Research

Volumn 226, Issue 2-3, 2015, Pages 494-498

  Yokoyama, Katsutoshi ^a   Yamada, Takeshi ^b   Mitani, Hideaki ^a   Yamada, Sayaka ^a   Pu, Shenghong ^a   Yamanashi, Takehiko ^a   Matsumura, Hiroshi ^a   Nakagome, Kazuyuki ^c   Kaneko, Koichi ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b Kurayoshi Hospital   (Japan)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

Author keywords

Depression; Dexamethasone (DEX CRH) test; Diabetes; Homeostasis model assessment of insulin resistance (HOMA R); Hypothalamic Pituitary Adrenal (HPA) axis; Insulin resistance

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; GLUCOSE; HYDROCORTISONE; BIOLOGICAL MARKER; INSULIN;

AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOCRINE DISEASE; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE DETERMINATION; HOSPITAL PATIENT; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM DYSREGULATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; AGING; BLOOD; CROSS-SECTIONAL STUDY; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY;

AGED; AGING; BIOLOGICAL MARKERS; CORTICOTROPIN-RELEASING HORMONE; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM;

EID: 84925332327     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2015.01.026     Document Type: Article

References (38)

1. Beekman A.T., Copeland J.R., Prince M.J. Review of community prevalence of depression in later life. British Journal of Psychiatry 1999, 174:307-311.
2. Bergman R.N., Ader M. Atypical antipsychotics and glucose homeostasis. Journal of Clinical Psychiatry 2005, 66:504-514.
3. Brown E.S., Varghese F.P., McEwen B.S. Association of depression with medical illness: does cortisol play a role?. Biological Psychiatry 2004, 55:1-9.
4. Bschor T., Ritter D., Winkelmann P., Erbe S., Uhr M., Ising M., Lewitzka U. Lithium monotherapy increases ACTH and cortisol response in the DEX/CRH test in unipolar depressed subjects. A study with 30 treatment-naive patients. PLoS One 2011, 6:e27613.
5. Carpenter L.L., Ross N.S., Tyrka A.R., Anderson G.M., Kelly M., Price L.H. Dex/CRH test cortisol response in outpatients with major depression and matched healthy controls. Psychoneuroendocrinology 2009, 34:1208-1213.
6. Christensen K., Doblhammer G., Rau R., Vaupel J.W. Ageing populations: the challenges ahead. Lancet 2009, 374:1196-1208.
7. Danaei G., Finucane M.M., Lu Y., Singh G.M., Cowan M.J., Paciorek C.J., Lin J.K., Farzadfar F., Khang Y.H., Stevens G.A., Rao M., Ali M.K., Riley L.M., Robinson C.A., Ezzati M. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011, 378:31-40.
8. Di Dalmazi G., Pagotto U., Pasquali R., Vicennati V. Glucocorticoids and type 2 diabetes: from physiology to pathology. Journal of Nutrition and Metabolism 2012, 2012:525093.
9. Folstein M., Folstein S., McHugh P. "Mini-mental State": a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12:189-198.
10. Gavard J.A., Lustman P.J., Clouse R.E. Prevalence of depression in adults with diabetes. An epidemiological evaluation. Diabetes Care 1993, 16:1167-1178.
11. Gervasoni N., Bertschy G., Osiek C., Perret G., Denis R., Golaz J., Rossier M.F., Bondolfi G., Aubry J.M. Cortisol responses to combined dexamethasone/CRH test in outpatients with a major depressive episode. Journal of Psychiatric Research 2004, 38:553-557.
12. Golden S.H., Williams J.E., Ford D.E., Yeh H.C., Paton Sanford C., Nieto F.J., Brancati F.L. Depressive symptoms and the risk of type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 2004, 27:429-435.
13. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960, 23:56-62.
14. Hatzinger M., Brand S., Herzig N., Holsboer-Trachsler E. In healthy young and elderly adults, hypothalamic-pituitary-adrenocortical axis reactivity (HPA AR) varies with increasing pharmacological challenge and with age, but not with gender. Journal of Psychiatric Research 2011, 45:1373-1380.
15. Iwata M., Ota K.T., Duman R.S. The inflammasome: pathways linking psychological stress, depression, and systemic illnesses. Brain, Behavior, and Immunity 2013, 31:105-114.
16. Kunugi H., Hori H., Numakawa T., Ota M. The hypothalamic-pituitary-adrenal axis and depressive disorder: recent progress. Nihon Shinkei Seishin Yakurigaku Zasshi 2012, 32:203-209.
17. Kunugi H., Ida I., Owashi T., Kimura M., Inoue Y., Nakagawa S., Yabana T., Urushibara T., Kanai R., Aihara M., Yuuki N., Otsubo T., Oshima A., Kudo K., Inoue T., Kitaichi Y., Shirakawa O., Isogawa K., Nagayama H., Kamijima K., Nanko S., Kanba S., Higuchi T., Mikuni M. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study. Neuropsychopharmacology 2006, 31:212-220.
18. Kunugi H., Urushibara T., Nanko S. Combined DEX/CRH test among Japanese patients with major depression. Journal of Psychiatric Research 2004, 38:123-128.
19. Kunzel H.E., Binder E.B., Nickel T., Ising M., Fuchs B., Majer M., Pfennig A., Ernst G., Kern N., Schmid D.A., Uhr M., Holsboer F., Modell S. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test. Neuropsychopharmacology 2003, 28:2169-2178.
20. Manoudi F., Chagh R., Benhima I., Asri F., Diouri A., Tazi I. Depressive disorders in diabetic patients. Encephale 2012, 38:404-410.
21. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
22. Meigs J.B. Epidemiology of the insulin resistance syndrome. Current Diabetes Reports 2003, 3:73-79.
23. Mezuk B., Edwards L., Lohman M., Choi M., Lapane K. Depression and frailty in later life: a synthetic review. International Journal of Geriatric Psychiatry 2012, 27:879-892.
24. Mihic M., Modi P. Metabolic syndrome-risk factors for atherosclerosis and diabetes. Current Diabetes Reviews 2008, 4:122-128.
25. Mondelli V., Dazzan P., Hepgul N., Di Forti M., Aas M., D'Albenzio A., Di Nicola M., Fisher H., Handley R., Marques T.R., Morgan C., Navari S., Taylor H., Papadopoulos A., Aitchison K.J., Murray R.M., Pariante C.M. Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment. Schizophrenia Research 2010, 116:234-242.
26. Naismith S.L., Norrie L.M., Mowszowski L., Hickie I.B. The neurobiology of depression in later-life: clinical, neuropsychological, neuroimaging and pathophysiological features. Progress in Neurobiology 2012, 98:99-143.
27. Owashi T., Otsubo T., Oshima A., Nakagome K., Higuchi T., Kamijima K. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression. Psychoneuroendocrinology 2008, 33:152-161.
28. Pariante C.M., Lightman S.L. The HPA axis in major depression: classical theories and new developments. Trends in Neurosciences 2008, 31:464-468.
29. Prague J.K., May S., Whitelaw B.C. Cushing's syndrome. BMJ 2013, 346:f945. (Clinical research ed.).
30. Rizza R.A., Mandarino L.J., Gerich J.E. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. Journal of Clinical Endocrinology and Metabolism 1982, 54:131-138.
31. Rowe J.W., Minaker K.L., Pallotta J.A., Flier J.S. Characterization of the insulin resistance of aging. Journal of Clinical Investigation 1983, 71:1581-1587.
32. Schillerstrom J.E., Royall D.R., Palmer R.F. Depression, disability and intermediate pathways: a review of longitudinal studies in elders. Journal of Geriatric Psychiatry and Neurology 2008, 21:183-197.
33. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 1998, 59(Suppl. 20):S22-S33. quiz 34-57.
34. Snowdon J. Is depression more prevalent in old age?. Australian and New Zealand Journal of Psychiatry 2001, 35:782-787.
35. Takeshita J., Masaki K., Ahmed I., Foley D.J., Li Y.Q., Chen R., Fujii D., Ross G.W., Petrovitch H., White L. Are depressive symptoms a risk factor for mortality in elderly Japanese American men?: the Honolulu-Asia Aging Study. American Journal of Psychiatry 2002, 159:1127-1132.
36. Tjokroprawiro A. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer). Acta Medica Indonesiana 2006, 38:160-166.
37. Travison T.G., O'Donnell A.B., Araujo A.B., Matsumoto A.M., McKinlay J.B. Cortisol levels and measures of body composition in middle-aged and older men. Clinical Endocrinology 2007, 67:71-77.
38. Wallace T.M., Levy J.C., Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 2004, 27:1487-1495.